Federal Circuit confirms ‘on-sale’ patent rules in MedCo v Hospira


An en banc US Court of Appeals for the Federal Circuit said yesterday that two patents owned by The Medicines Company (MedCo) are valid in a case setting the rules for ‘on-sale’ product-by process patents.

MedCo, Hospira, Federal Circuit, Angiomax, bivalirudin, patent, on-sale patent bar